A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Following Subcutaneous Injection of JNJ-64304500 in Healthy Japanese and Caucasian Male Participants
Clinical trial NCT03002025 · COMPLETED
Trial details
- NCT number
- NCT03002025
- Sponsor
- Janssen Pharmaceutical K.K.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-10
- Primary completion
- 2017-09-09
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.